SCHEMBL13014752

SCHEMBL13014752

COCC(C)NC(=O)c1cc(NC(=O)c2ccccn2)cc(-c2ccc(C)cc2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13014751 0.87 FABP1 (0.58)
SCHEMBL13014762 0.87
SCHEMBL13014779 0.85 NPC1 (0.52)
SCHEMBL13014742 0.82
SCHEMBL13014765 0.81 MEN1 (0.53)
SCHEMBL13014756 0.81
SCHEMBL13014749 0.81
SCHEMBL13014746 0.81
SCHEMBL2274832 0.80
SCHEMBL13014745 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170057932-A1 BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS ROCHE PALO ALTO LLC (US) 2017-03-02 US disclosed
US-9505726-B2 Substituted biphenyl amides as P2X3 and P2X2/3 antagonists ROCHE PALO ALTO LLC (US) 2016-11-29 US disclosed
US-20150080408-A1 PYRIDINYL AMIDES AS P2X3 AND P2X2/3 INHIBITORS ROCHE PALO ALTO LLC (US) 2015-03-19 US disclosed
US-8283383-B2 Biphenyl amides as P2X3 and P2X2/3 antagonists ROCHE PALO ALTO LLC (US) 2012-10-09 US disclosed
US-8283383-B2 Biphenyl amides as P2X3 and P2X2/3 antagonists ROCHE PALO ALTO LLC (US) 2012-10-09 US disclosed
WO-2010149578-A2 NOVEL BIPHENYL AND PHENYL-PYRIDINE AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-12-29 WO disclosed
US-20100324056-A1 BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS BROKA CHRIS ALLEN 2010-12-23 US disclosed
US-20100324056-A1 BIPHENYL AND PHENYL-PYRIDINE AMIDES AS P2X3 AND P2X2/3 ANTAGONISTS BROKA CHRIS ALLEN 2010-12-23 US disclosed